アトピー性皮膚炎市場レポート：2030年までの動向、予測、競合分析

アトピー性皮膚炎の動向と予測

世界のアトピー性皮膚炎市場は、2024年から2030年までのCAGRが9.4%で、2030年までに推定233億米ドルに達すると予想されます。この市場の主な促進要因は、迅速な技術進歩と資金調達の増加、それに研究開発に対する政府支援の増加です。世界のアトピー性皮膚炎市場の将来は、病院薬局、小売薬局、オンライン薬局の各市場における機会によって有望視されています。

セグメント別のアトピー性皮膚炎

アトピー性皮膚炎の世界市場について、薬剤クラス別、投与方法別、流通チャネル別、地域別の予測を掲載しています。

アトピー性皮膚炎市場の洞察

Lucintel社の予測によると、アトピー性皮膚炎に対する治療法の認知度向上により、予測期間中は生物学的製剤が最も高い成長を遂げる見込みです。

同市場では、アトピー性皮膚炎の有病率が顕著であることから、病院薬局が最大セグメントであり続けると思われます。

北米は、患者の間で治療に対する意識が高まっていることと、同地域に多くの自社メーカーが存在することから、予測期間中も最大の地域であり続けると思われます。

よくある質問

Q1.市場規模は：

A1.世界のアトピー性皮膚炎市場は、2030年までに推定233億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.アトピー性皮膚炎の世界市場は、2024年から2030年にかけてCAGR 9.4%で成長すると予測されています。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、迅速な技術進歩と資金調達の増加であり、研究開発に対する政府の支援も増加しています。

Q4.市場の主要セグメントは：

A4.アトピー性皮膚炎市場の将来は、病院薬局、小売薬局、オンライン薬局の各市場における機会により有望視されています。

Q5.市場の主要企業は：

A5.アトピー性皮膚炎の主要企業は以下の通り：

• Bayer
• AbbVie
• Incyte
• Novartis International
• Arcutis Biotherapeutics
• Bristol-Myers Squibb
• Regeneron Pharmaceuticals

Q6.今後、最大となる市場セグメントは：

A6.Lucintelの予測では、アトピー性皮膚炎の治療法に関する認知度の上昇により、予測期間中に最も高い成長が見込まれるのは生物学的製剤です。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、患者の間で治療に対する意識が高まっていること、また同地域に多くの自社メーカーが存在することから、予測期間中も最大の地域です。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のアトピー性皮膚炎市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のアトピー性皮膚炎市場の動向（2018～2023年）と予測（2024～2030年）
• 薬剤クラス別のアトピー性皮膚炎の世界市場
  • PDE-4阻害剤
  • コルチコステロイド
  • 生物学的製剤
  • カルシニューリン阻害剤
  • その他
• 投与方法別のアトピー性皮膚炎の世界市場
  • 局所
  • 注射
  • 経口
• 流通チャネル別のアトピー性皮膚炎の世界市場
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別のアトピー性皮膚炎の世界市場
• 北米のアトピー性皮膚炎市場
• 欧州のアトピー性皮膚炎市場
• アジア太平洋地域のアトピー性皮膚炎市場
• その他地域のアトピー性皮膚炎市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
• 世界のアトピー性皮膚炎市場の新たな動向
• 戦略分析
  • 新製品の開発
  • 世界のアトピー性皮膚炎市場の能力拡大
  • 世界のアトピー性皮膚炎市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Bayer
• AbbVie
• Incyte
• Novartis International
• Arcutis Biotherapeutics
• Bristol-Myers Squibb
• Regeneron Pharmaceuticals

Atopic Dermatitis Trends and Forecast

The future of the global atopic dermatitis market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global atopic dermatitis market is expected to reach an estimated $23.3 billion by 2030 with a CAGR of 9.4% from 2024 to 2030. The major drivers for this market are swift technological advancement and increase in funding, coupled with a rise in government support for research and development.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Atopic Dermatitis by Segment

The study includes a forecast for the global atopic dermatitis by drug class, mode of administration, distribution channel, and region.

Atopic Dermatitis Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• PDE-4 Inhibitor
• Corticosteroids
• Biologics
• Calcineurin Inhibitors
• Others

Atopic Dermatitis Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Topical
• Injectable
• Oral

Atopic Dermatitis Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Atopic Dermatitis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Atopic Dermatitis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies atopic dermatitis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the atopic dermatitis companies profiled in this report include-

• Bayer
• AbbVie
• Incyte
• Novartis International
• Arcutis Biotherapeutics
• Bristol-Myers Squibb
• Regeneron Pharmaceuticals

Atopic Dermatitis Market Insights

Lucintel forecasts that biologic is expected to witness the highest growth over the forecast period due to rise in awareness regarding the availability of treatments for the disease.

Within this market, hospital pharmacy will remain the largest segment due to notable prevalence of atopic dermatitis.

North America will remain the largest region over the forecast period due to growing treatment awareness among the patient population and existence of substantial in-house manufacturers in the region.

Features of the Global Atopic Dermatitis Market

Market Size Estimates: Atopic dermatitis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Atopic dermatitis market size by drug class, mode of administration, distribution channel, and region in terms of value ($B).

Regional Analysis: Atopic dermatitis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug classes, mode of administration, distribution channels, and regions for the atopic dermatitis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the atopic dermatitis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the atopic dermatitis market size?

Answer: The global atopic dermatitis market is expected to reach an estimated $23.3 billion by 2030.

Q2. What is the growth forecast for atopic dermatitis market?

Answer: The global atopic dermatitis market is expected to grow with a CAGR of 9.4% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the atopic dermatitis market?

Answer: The major drivers for this market are swift technological advancement and increase in funding, coupled with a rise in government support for research and development.

Q4. What are the major segments for atopic dermatitis market?

Answer: The future of the atopic dermatitis market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q5. Who are the key atopic dermatitis market companies?

Answer: Some of the key atopic dermatitis companies are as follows:

• Bayer
• AbbVie
• Incyte
• Novartis International
• Arcutis Biotherapeutics
• Bristol-Myers Squibb
• Regeneron Pharmaceuticals

Q6. Which atopic dermatitis market segment will be the largest in future?

Answer: Lucintel forecasts that biologic is expected to witness the highest growth over the forecast period due to rise in awareness regarding the availability of treatments for the disease.

Q7. In atopic dermatitis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing treatment awareness among the patient population and existence of substantial in-house manufacturers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the atopic dermatitis market by drug class (PDE-4 inhibitor, corticosteroids, biologics, calcineurin inhibitors, and others), mode of administration (topical, injectable, and oral), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Atopic Dermatitis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Atopic Dermatitis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Atopic Dermatitis Market by Drug Class
  • 3.3.1: PDE-4 Inhibitor
  • 3.3.2: Corticosteroids
  • 3.3.3: Biologics
  • 3.3.4: Calcineurin Inhibitors
  • 3.3.5: Others
• 3.4: Global Atopic Dermatitis Market by Mode of Administration
  • 3.4.1: Topical
  • 3.4.2: Injectable
  • 3.4.3: Oral
• 3.5: Global Atopic Dermatitis Market by Distribution Channel
  • 3.5.1: Hospital Pharmacies
  • 3.5.2: Retail Pharmacies
  • 3.5.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Atopic Dermatitis Market by Region
• 4.2: North American Atopic Dermatitis Market
  • 4.2.1: North American Atopic Dermatitis Market by Drug Class: PDE-4 Inhibitor, Corticosteroids, Biologics, Calcineurin Inhibitors, and Others
  • 4.2.2: North American Atopic Dermatitis Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.3: European Atopic Dermatitis Market
  • 4.3.1: European Atopic Dermatitis Market by Drug Class: PDE-4 Inhibitor, Corticosteroids, Biologics, Calcineurin Inhibitors, and Others
  • 4.3.2: European Atopic Dermatitis Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.4: APAC Atopic Dermatitis Market
  • 4.4.1: APAC Atopic Dermatitis Market by Drug Class: PDE-4 Inhibitor, Corticosteroids, Biologics, Calcineurin Inhibitors, and Others
  • 4.4.2: APAC Atopic Dermatitis Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.5: ROW Atopic Dermatitis Market
  • 4.5.1: ROW Atopic Dermatitis Market by Drug Class: PDE-4 Inhibitor, Corticosteroids, Biologics, Calcineurin Inhibitors, and Others
  • 4.5.2: ROW Atopic Dermatitis Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Atopic Dermatitis Market by Drug Class
  • 6.1.2: Growth Opportunities for the Global Atopic Dermatitis Market by Mode of Administration
  • 6.1.3: Growth Opportunities for the Global Atopic Dermatitis Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Atopic Dermatitis Market by Region
• 6.2: Emerging Trends in the Global Atopic Dermatitis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Atopic Dermatitis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Atopic Dermatitis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bayer
• 7.2: AbbVie
• 7.3: Incyte
• 7.4: Novartis International
• 7.5: Arcutis Biotherapeutics
• 7.6: Bristol-Myers Squibb
• 7.7: Regeneron Pharmaceuticals